EXTRAHEPATIC MANIFESTATIONS IN PATIENTS WITH ACUTE HEPATITIS E – PAZARDZHIK, BULGARIA 2014 – 2022

Authors

  • M. Pishmisheva Department of Infectious Diseases, Pazardzhik Multiprofile Hospital for Active Treatment Author
  • Stanislav Kotsev Department of Infectious Diseases, Pazardzhik Multiprofile Hospital for Active Treatment Author
  • E. Golkocheva-Markova National Reference Laboratory "Hepatitis Viruses", Department of Virology, National Centre for Infectious and Parasitic Diseases, Sofia, Bulgaria. Author
  • R. Argirova Laboratory of Virology, Acibadem City Clinic, Tokuda Hospital, Sofia, Bulgaria Author

DOI:

https://doi.org/10.58395/sdrgfr19

Keywords:

HEV, extrahepatic manifestations, thrombocytopenia, CK elevation, acute pancreatitis

Abstract

BACKGROUND: Hepatitis E is a global health issue, only partially understood. Bulgarian record started in 2019 and data is not sufficient.

AIM: This research aims to analyze extrahepatic manifestation of acute hepatitis E in patients with hepatitis E from Pazardzhik region, between 2014 – 2022.

MATERIALS AND METHODS: The analysis includes 247 patients with acute hepatitis E, treated at the Department of Infectious Diseases of Pazardzhik Multiprofile Hospital for Active Treatment, Bulgaria between 2014 – 2022. The methodology includes clinical observation, laboratory tests and medical imaging. The diagnosis was established by serological /ELISA for anti-HEV IgM, IgG detection/and molecular-biological tests /RT-PCR for HEV RNA detection/.

RESULTS: We observed extrahepatic manifestations in 19% (47/247) of the cases. In 60% (28/47) comorbidities were present, and 9% (4/47) were with underlying acute/chronic coinfection with another hepatotropic virus. Thrombocytopenia was found in 83% (39/47) of the patients; asymptomatic creatine kinase elevation – in 13% (6/47), acute pancreatitis – in 9% (4/47), transitory renal impairent – in 6% (3/47); 2% (1/47) had Guillain-Barré syndrome (GBS), 2% (1/47) – arrhythmia and 13% (6/47) – multiorgan involvement. While 91% (43/47) of the patients recovered, in 9% (4/47) the outcome was fatal.

CONCLUSION: Extrahepatic manifestations might prevail, potentially delaying diagnosis of HEV-infection. Symptoms associated with comorbidities might also impede the final diagnosis. A diagnostic algorithm is needed to enhance the accurate diagnosis of HEV in patients with dubious symptoms.

Downloads

Download data is not yet available.

References

1. Anderson D. Hepatitis E. In: Mandell G, Bennett J, Dolin R, Herausgeber. Principles and Practice of Infectious Diseases. 7. Aufl. Philadelphia: Elsevier; 2010. S. 2411–21.

2. Donnelly MC, Scobie L, Crossan CL, Dalton H, Hayes PC, Simpson KJ. Hepatitis E- a concise review of virology, epidemiology, clinical presentation, and therapy. Aliment Pharmacol Ther. 2017;46(2):126–41. https://doi.org/10.1111/apt.14109

3. Pérez-Gracia MT, García M, Suay B, Mateos-Lindemann ML. Current knowledge on hepatitis E. Bd. 3, J Clin and Transl Hepatol Xia and He Publishing Inc.; 2015. S. 117–26. https://doi.org/10.14218/JCTH.2015.00009

4. Drave SA, Debing Y, Walter S, Todt D, Engelmann M, Friesland M, u. a. Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells. J Viral Hepat. 2016;23(7):512–21. https://doi.org/10.1111/jvh.12515

5. Horvatits T, Pischke S. Extrahepatic manifestations and HEV, the genotype matters. EBioMedicine. 2018;36:3–4. https://doi.org/10.1016/j.ebiom.2018.09.004

6. Rawla P, Raj JP, Kannemkuzhiyil AJ, Aluru JS, Thandra KC, Gajendran M. A Systematic Review of the Extra-Hepatic Manifestations of Hepatitis E Virus Infection. Med Sci. 2020;8(1):9. https://doi.org/10.3390/medsci8010009

7. Fousekis FS, Mitselos I V., Christodoulou DK. Extrahepatic manifestations of hepatitis E virus: An overview. Clin Mol Hepatol. 2020;26(1):16–23. https://doi.org/10.3350/cmh.2019.0082

8. Teoharov P, Tiholova M, Draganov P, Lilianova V. The first case of hepatitis E infection in Bulgaria. Infectology.1995;(3):17–8.(in Bulgarian)

9. Pishmisheva-Peleva M. Clinical-epidemiological aspects of the acute hepatitis E virus infection. [Dissertation] Plovdiv, Medical University of Plovdiv, 2018 (in Bulgarian)

10. Pishmisheva-Peleva M. Hepatitis E – exotics or silent presence. [Monograph] Pazardzhik, Barich, 2022. (in Bulgarian)

11. Pishmisheva M, Baymakova M, Hepatitis E virus infection: underrated and unrecognized. Medical Review 2014;6(50):5–12. (in Bulgarian)

12. Teoharov P, Pishmisheva M, Kovaliova V. A case of hepatitis E virus infection. Infectology. 2008;(1):43–4. (in Bulgarian)

13. Pishmisheva M, Petrov A, Stoycheva M. Holestasis syndrome in hepatitis E – challenges. 3. National symposium of, 2-4 June 2016, Tsigov chark. (oral presentation, in Bulgarian)

14. Pishmisheva M, Golkocheva-Markova E, Stoycheva M. Acute hepatitis E infection with persistent more than six months cholestasis syndrome. Science, infectology and parasitology, 2017;(1):22–6. (in Bulgarian)

15. Golkocheva-Markova E, Ismailova C, Tenev T, Nikolaeva-Glomb L. Studies on the epidemiological and molecular characteristics of hepatitis E virus in Bulgaria: a comprehensive review. Probl Infect Parasit Dis. 2022;49(3):27–44. https://doi.org/10.58395/pipd.v49i3.75

16. Golkocheva-Markova E, Kevorkyan A, Raycheva R, Ismailova C, Yoncheva V, Tenev T, u. a. Assessment of hepatitis E seropositivity among HIV-infected patients in Bulgaria. Braz J Infect Dis. 2022;26(1):102329. https://doi.org/10.1016/j.bjid.2022.102329

17. Bruni R, Villano U, Equestre M, Chionne P, Madonna E, Trandeva-Bankova D, u. a. Hepatitis E virus genotypes and subgenotypes causing acute hepatitis, Bulgaria, 2013–2015. PLoS One. 2018;13(6):e0198045. https://doi.org/10.1371/journal.pone.0198045

18. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295–300.

19. Pischke S, Hartl J, Pas SD, Lohse AW, Jacobs BC, Van der Eijk AA. Hepatitis E virus: Infection beyond the liver? J Hepatol. 2017;66(5):1082–95. https://doi.org/10.1016/j.jhep.2016.11.016

20. Scharn N, Ganzenmueller T, Wenzel JJ, Dengler R, Heim A, Wegner F. Guillain-Barré syndrome associated with autochthonous infection by hepatitis E virus subgenotype 3c.Infection. 2014;42(1). https://doi.org/10.1007/s15010-013-0448-5

21. Deniel C, Coton T, Brardjanian S, Guisset M, Nicand E, Simon F. Acute pancreatitis: A rare complication of acute hepatitis E. J ClinVir. 2011;51(3). https://doi.org/10.1016/j.jcv.2011.04.009

22. Fourquet E, Mansuy JM, Bureau C, Recher C, Vinel JP, Izopet J, u. a. Severe thrombocytopenia associated with acute autochthonous hepatitis E. Bd. 48, J Clin Vir 2010. https://doi.org/ 10.1016/j.jcv.2010.02.016

23. Guinault D, Ribes D, Delas A, Milongo D, Abravanel F, Puissant-Lubrano B, u. a. Hepatitis e virus-induced cryoglobulinemic glomerulonephritis in a nonimmunocompromised person. American Journal of Kidney Diseases. 2016;67(4). https://doi.org/10.1053/j.ajkd.2015.10.022

24. Wu J, Xiang Z, Zhu C, Yao Y, Bortolanza M, Cao H, u. a. Extrahepatic manifestations related to hepatitis E virus infection and their triggering mechanisms. Journal of Infection. 2021;83(3):298–305. https://doi.org/10.1016/j.jinf.2021.07.021

25. Mandal K, Chopra N. Acute transverse myelitis following hepatitis E virus infection. Bd. 43, Indian Pediatrics 2006.

26. Deroux A, Brion JP, Hyerle L, Belbezier A, Vaillant M, Mosnier E, u. a. Association between hepatitis E and neurological disorders: Two case studies and literature review. Journal of Clinical Virology. 2014;60(1). https://doi.org/10.1016/j.jcv.2014.01.026

27. Haffar S, Bazerbachi F, Garg S, Lake JR, Freeman ML. Frequency and prognosis of acute pancreatitis associated with acute hepatitis E: A systematic review. Bd. 15, Pancreatology 2015;15(4):321-326. https://doi.org/10.1016/j.pan.2015.05.460

28. Bazerbachi F, Haffar S, Garg SK, Lake JR. Extra-hepatic manifestations associated with hepatitis E virus infection: a comprehensive review of the literature. Gastroenterol Rep (Oxf). 2016;4(1):1–15. https://doi.org/10.1093/gastro/gov042

29. Mishra P, Mahapatra M, Kumar R, Pati HP. Autoimmune hemolytic anemia and erythroid hypoplasia associated with hepatitis E [5]. Bd. 26, Indian J Gastroenterol 2007, 26(4), 195-196.

30. Hagler L, Pastore RA, Bergin JJ, Wrensch MR. Aplastic anemia following viral hepatitis: Report of two fatal cases and literature review. Medicine (United States). 1975;54(2). https://doi.org/10.1097/00005792-197554020-00003

31. George M. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014; https://doi.org/10.2147/jbm.s46255

32. Kitazawa T, Ota Y, Suzuki M, Morisawa Y, Shintani Y, Koike K, u. a. Acute hepatitis E with elevated creatine phosphokinase. Intern Med. 2003;42(9). https://doi.org/10.2169/internalmedicine.42.899

33. Al-Shukri I, Davidson E, Tan A, Smith DB, Wellington L, Johannessen I, u. a. Rash and arthralgia caused by hepatitis e. The Lancet. 2013;382(9907). https://doi.org/10.1016/S0140-6736(13)62074-7

34. Dalton HR, Kamar N, Baylis SA, Moradpour D, Wedemeyer H, Negro F. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. Elsevier B.V.; 2018;68(6):1256–71. https://doi.org/10.1016/j.jhep.2018.03.005

Downloads

Published

2024-09-15

Issue

Section

Articles

How to Cite

(1)
Pishmisheva-Peleva, M.; Kotsev, S.; Golkocheva-Markova, E.; Argirova, R. EXTRAHEPATIC MANIFESTATIONS IN PATIENTS WITH ACUTE HEPATITIS E – PAZARDZHIK, BULGARIA 2014 – 2022. Probl Infect Parasit Dis 2024, 52 (2), 5-10. https://doi.org/10.58395/sdrgfr19.